Using scoring tools to predict liver transplant outcomes
Part of Digestive system clinical trials.
This study looks at whether different scoring tools can better predict outcomes for people with cirrhosis who are waiting for a liver transplant. It may help improve how transplant urgency is decided.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old.
- Have liver cirrhosis (scarring of the liver) from any cause.
- Be on the liver transplant waiting list.
- Not have factors like severe infection, serious heart or lung problems, or active cancer.
- Not have transplant indications other than the standard MELD scoring system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing new scoring systems to better predict outcomes for people hospitalized with serious liver cirrhosis complications. It may help doctors understand which patients need more intensive care.
This study looks at new scoring systems to predict how patients with acute-on-chronic liver failure (a sudden worsening of long-term liver disease) will do. It may help doctors better understand and treat this condition.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This study looks at a prediction tool that estimates outcomes for people with liver cancer and cirrhosis, to help decide whether a liver transplant is a good option. It may help doctors choose the right timing and patients who could benefit most from transplantation.
This study develops a score to predict infection risk right after a liver transplant. It uses blood samples from transplant day to identify which patients are more likely to get infections, helping doctors tailor care.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.